Information:
Error:
ID
11720
Description
The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively. https://clinicaltrials.gov/ct2/show/NCT00767507
Link
https://clinicaltrials.gov/ct2/show/NCT00767507
Keywords
Versions (1)
- 7/28/15 7/28/15 -
Uploaded on
July 28, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Bridge Acute Coronary Syndrome NCT00767507
Similar models
Eligibility Criteria
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Informed consent
Item
Written informed consent
boolean
C0021430 (UMLS CUI-1)
Age
Item
18 Years of Age
boolean
C0001779 (UMLS CUI-1)
CABG
Item
Non emergent coronary bypass graft surgery
boolean
C0010055 (UMLS CUI-1)
Thienopyridines
Item
Received a thienopyridine within 48 hours prior to enrollment
boolean
C2936588 (UMLS CUI-1)
Pregnancy
Item
Confirmed or suspected pregnancy
boolean
C0549206 (UMLS CUI-1)
Stroke
Item
Cerebrovascular accident within one yar
boolean
C0038454 (UMLS CUI-1)
Intracranial neoplasm
Item
Intracranial neoplasm
boolean
C1527390 (UMLS CUI-1)
Bleeding risk
Item
History of bleeding diathesis
boolean
C3251812 (UMLS CUI-1)
Thrombocytopenia
Item
Thrombocytopenia
boolean
C0040034 (UMLS CUI-1)